Skip to main content

The effect of time and temperature variables on routine coagulation tests.

Adcock D, Kressin D, Marlar RA

Publication: Blood Coagul Fibrinolysis (1998) • Vol 9 • Page 463-70PMID: 9818995View on PubMed

Purpose

The purpose of this paper was to determine the effects of oral anticoagulant therapy and storage of blood or plasma on prothrombin time (PT) and activated partial thromboplastin time (APTT) in normal subjects and hospitalized patients.

Conclusion

PT changed less than 10% after storage of whole blood or plasma at room temperature or on ice for up to 24 h. APTT increased steadily with time in specimens from healthy subjects and hospital patients not receiving unfractionated heparin, but most changes were less than 10% until 8 h and no consistent effects of storage temperature were found. In patients receiving unfractionated heparin, APTT decreased rapidly with storage of whole blood but decreased only slightly when plasma was stored. In conclusion, blood and plasma specimens from patients not receiving heparin may be stored at 4 degrees C or room temperature for up to 8 h prior to analysis, but for patients receiving heparin, specimens must be centrifuged within 1 h at room temperature or within 4 h at 4 degrees C.

Studies (1)

Purpose

The purpose of this study was to determine the effects of oral anticoagulant therapy and storage of blood or plasma at room temperature or on ice on PT and APTT in normal subjects and hospitalized patients.

Summary of Findings

PT changed less than 10% after storage of whole blood or plasma at room temperature or on ice for up to 24 h. APTT increased steadily over the 24 h period in specimens from healthy subjects (8.3-16.7%), and hospital patients not receiving unfractionated heparin (9.6-12.6%), but most changes were less than 10% until 8 h and no consistent effects of storage temperature were found. In patients receiving unfractionated heparin, APTT decreased rapidly over the 24 h period when stored as whole blood (33.1-35.6%) but decreased only slightly when plasma was stored (4.4-10.6%). Importantly, the effect of whole blood storage at room temperature in patients receiving unfractionated heparin could be observed as early as 2 h, but no effect was seen until at least 4 h when whole blood specimens were stored on ice. In conclusion, blood and plasma specimens from patients not receiving heparin may be stored at 4 degrees C or room temperature for up to 8 h prior to analysis, but for patients receiving heparin, specimens must be centrifuged within 1 h at room temperature or within 4 h at 4 degrees C.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
    Other diagnoses
  • Platforms

    MorphologyHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Hospitalized patient
    Normal
    PreaquisitionOther drugs
    Coumadin
    No anticoagulant therapy
    Unfractionated heparin
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Whole blood
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageStorage duration
    24 h
    4 h
    6 h
    8 h
    Less than 1 h
    StorageStorage temperature
    On ice
    Room temperature